Skip Navigation



Rheumatology Advance Access published online on May 25, 2004

Rheumatology, doi:10.1093/rheumatology/keh238
Rheumatology © British Society for Rheumatology 2004; all rights reserved
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/8/1039    most recent
keh238v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stoll, T.
Right arrow Articles by Isenberg, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoll, T.
Right arrow Articles by Isenberg, D. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received August 12, 2003
Revised April 15, 2004

Original Papers

Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study

T. Stoll 1*, N. Sutcliffe 2, J. Mach 1, R. Klaghofer 3, D. A. Isenberg 2

1 aarReha, CH-5116 Schinznach-Bad, Switzerland
2 Centre for Rheumatology, Department of Medicine, University College London, UK
3 Division of Psychosocial Medicine, University Hospital Zürich, CH-8091 Zürich, Switzerland

* To whom correspondence should be addressed. E-mail: thomas.stoll{at}aarreha.ch.


   Abstract

Objective. To determine whether initial damage, disease duration, age, initial health status, average disease activity over the 5 yr or an average medication score covering the follow-up period would predict an increase in damage in patients with systemic lupus erythematosus (SLE) within the next 5 yr.

Methods. A 5-yr prospective longitudinal study of a cohort of 141 consecutive patients with SLE attending a specialist lupus out-patient clinic in London from their first assessment between July 1994 and February 1995. Disease activity was assessed using the BILAG system, initial health status by the Medical Outcome Survey Short Form 20 with an extra question about fatigue (SF-20+) and damage by the SLICC/ACR Damage Index (SDI). Damage was reassessed 5 yr later. Statistical analysis was carried out using multiple logistic regression analysis (logXact).

Results. One hundred and thirty-three female and eight male SLE patients (97 Caucasians, 16 Afro-Caribbeans, 22 Asians and 6 others) were included, their age at inclusion was 41.1 ± 12.5 yr and their disease duration 10.2 ± 6.3 yr. The mean measures at inclusion were: total BILAG 5.2 (range 0-17), total SDI 1.2 (0-7) and medication score 1.2 (0-3). Six patients were lost to follow-up because they had moved. Of the remaining 135 patients total damage had increased in 40 patients and 10 patients had died. At the end of the study, at 4.63 ± 0.19 yr, the total SDI had increased to 1.6 ± 1.7. Multiple logistic regression analysis revealed that death and increase in damage were strongly predicted by a high total disease activity over the entire study period (P<0.001) as we had hypothesized. When the total BILAG score was replaced by the average number of A-flares the prediction of accrual of damage during the study period was again highly significant (P = 0.004).

Conclusions. In this first prospective study of its type a highly significant impact of total disease activity, as measured over 5 yr using the BILAG system, on the development of total damage was revealed. Moreover, these results provide further proof of the validity of the SDI and support the BILAG concept of the A-flares.

KEY WORDS: SLE, SLE, Disease activity, BILAG, Damage, SLICC/ACR Damage Index, SF-20.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
LupusHome page
A.M. Bertoli, L.M. Vila, M. Apte, B.J. Fessler, H.M. Bastian, J.D. Reveille, and G.S. Alarcon
Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage
Lupus, June 1, 2007; 16(6): 410 - 417.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
D. Paran, D. Caspi, D. Levartovsky, O. Elkayam, I. Kaufman, I. Litinsky, G. Keren, and B. Koifman
Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome
Ann Rheum Dis, April 1, 2007; 66(4): 506 - 510.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. Allen, V. T. Farewell, D. A. Isenberg, and C. Gordon
A statistical analysis of the interrelationships between disease activity in different systems in systemic lupus erythematosus
Rheumatology, March 1, 2006; 45(3): 308 - 313.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.